
I-Ultra-minimum incision personalized intratumoral chemoimmunotherapy inikeza indlela eqondiwe ekwelapheni umdlavuza, kuncishiswe ukuhlasela kuyilapho kukhulisa ukusebenza kahle kokwelapha. Le nqubo emisha ihlanganisa ukunemba kokuhlinzwa okungenakuhlasela kancane ngamandla emithi yomuntu siqu kanye ne-immunotherapy, okuholela emiphumeleni ethuthukisiwe yesiguli kanye nemiphumela engemihle encishisiwe. Funda kabanzi mayelana nalokhu kuthuthuka okuyisisekelo ekunakekelweni komdlavuza.
Ukuhlinzwa komdlavuza okuvamile kuvame ukubandakanya ukusika okukhulu, okuholela ezikhathini ezinwetshiwe zokululama kanye nezibazi ezinkulu. Ukuhlinzwa kwe-Ultra-minimum incision kusebenzisa amathuluzi okuhlinza athuthukisiwe nezindlela zokwenza inqubo ngokusebenzisa izimbobo ezincane kakhulu. Lokhu kunciphisa ukuhlukumezeka kwezicubu, okuholela ebuhlungu obuncane, ukuphulukiswa okusheshayo, kanye nemiphumela yezimonyo ethuthukisiwe. Imvelo enembile yalezi zinqubo ivumela odokotela abahlinzayo ukuthi baqondise ngempumelelo isimila kuyilapho belondoloza izicubu ezinempilo ezizungezile.
I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy ibona izici eziyingqayizivele zofuzo namangqamuzana ethumba lesiguli ngasinye. Ngokuhlaziya lezi zici, izazi ze-oncologists zingakha uhlelo lokwelapha lomuntu siqu oluqondise kumangqamuzana omdlavuza ngenkathi esindisa amaseli anempilo. Le ndlela yomuntu siqu inyusa ukusebenza kokwelashwa futhi inciphisa ingozi yemiphumela engemihle eyingozi uma iqhathaniswa nezindlela ezivamile, ezilingana nosayizi owodwa.
Ukuphathwa kwe-chemotherapy kanye ne-immunotherapy ngqo ku-tumor (ukulethwa kwe-intratumoral) kuqinisekisa ukuthi ukuhlushwa okuphezulu kakhulu kwemithi kufinyelela ekuhlosweni, okwandisa ukusebenza kwayo. Le ndlela eqondisiwe inciphisa ukuchayeka okuhleliwe emithini, inciphisa amathuba okuba nemiphumela emibi kuwo wonke umzimba. Izindlela zokuletha ezihlukene zingasetshenziswa kuye ngohlobo oluthile lomdlavuza nendawo yesimila. Ucwaningo luqhubekela phambili luthuthuka kulo mkhakha, luhlola izindlela ezintsha nezisebenza ngempumelelo zokulethwa kwezidakamizwa ze-intratumoral.
Leli su lokwelapha lihlanganisa imiphumela ye-cytotoxic ye-chemotherapy namandla okuqinisa amasosha omzimba e-immunotherapy. I-Chemotherapy iwabulala ngokuqondile amangqamuzana omdlavuza, kuyilapho i-immunotherapy isiza amasosha omzimba ukubona futhi abhubhise amangqamuzana omdlavuza ngempumelelo kakhudlwana. Inhlanganisela yalezi zindlela zokwelapha ezimbili ezinamandla idala umphumela we-synergistic, ngokuvamile okuholela emazingeni okuphendula athuthukisiwe kanye nokuxolelwa okuhlala isikhathi eside.
Izinzuzo ze I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy zihlanganisa:
Ucwaningo oluningi kanye nezivivinyo zomtholampilo ziyaqhubeka ukuze kuqhutshekwe nophenyo ngokusebenza nokuphepha kwe I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy kuzo zonke izinhlobo zomdlavuza. Lezi zifundo zihlinzeka ngemininingwane ebalulekile kumasu okwelapha alungile kanye nezindlela zokukhetha isiguli. Ukuze uthole imiphumela yocwaningo lwakamuva, kunconywa ukuthi uthintane namajenali ezokwelapha abuyekezwe ngontanga kanye nezinhlangano ezihlonishwayo zocwaningo lomdlavuza. I I-Shandong Baofa Cancer Research Institute ubambe iqhaza elikhulu kulolu cwaningo oluqhubekayo.
Ngenkathi ngithembisa, I-Ultra-Minimum Incision Personalized Intratumoral Chemoimmunotherapy alinazo izinselele ezingase zibe khona. Lokhu kuhlanganisa isidingo samakhono akhethekile okuhlinza kanye nemishini, inkimbinkimbi yokuhlela ukwelashwa komuntu siqu, kanye namandla okuba nezinkinga ezingalindelekile. Ucwaningo olwengeziwe lubalulekile ukubhekana nalezi zinselele nokwandisa ukusetshenziswa kwale ndlela yokwelapha emisha. I I-Shandong Baofa Cancer Research Institute uzibophezele ekuthuthukiseni ulwazi nokusebenzisa lokhu kwelashwa.
eceleni>